Ultragenyx Pharmaceutical Inc 10-K for FY2024
Ultragenyx Pharmaceutical Inc. (RARE)
10-K
2025-02-19
For: 2024-12-31
View Original
Added on
April 09, 2026
About this 10-K
Ultragenyx Pharmaceutical Inc filed this 10-K on February 19, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $560.23M
- up 29.0% from $434.25M a year earlier
- Net loss
- $569.18M
- compared with a net loss of $606.64M a year earlier
- Diluted EPS
- -$6.29
- compared with -$8.25 a year earlier